Oncology & Cancer
Researchers find pathway to cancer-associated muscle weakness
Cancer researchers at Indiana University and their colleagues have discovered how cancer-induced bone destruction causes skeletal muscle weakness.
Oct 12, 2015
0
28
News tagged with bone metastases
Oncology & Cancer
Predicting advanced prostate cancer outcomes with NaF-PET/CT
A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium fluoride (Na-F-18) positron emission tomography/computed tomography (NaF-PET/CT) accurately detects bone metastases in patients ...
Jun 7, 2016
0
2
Oncology & Cancer
What wakes dormant tumor cells
Prostate tumor cells can be lulled to sleep by a factor released by bone cells, according to a study published online this week in the Journal of Experimental Medicine. Disease recurs in up to half of prostate cancer patients ...
Nov 28, 2011
0
0
Oncology & Cancer
Researchers focus on potential tool for predicting survival, staging prostate cancer
Researchers with the Indiana University School of Medicine have identified a molecule that promotes metastasis of advanced prostate cancer to the bone, an incurable condition that significantly decreases quality of life. ...
May 20, 2015
0
17
Oncology & Cancer
New non-invasive technique could revolutionize the imaging of metastatic cancer
Bioluminescence, nanoparticles, gene manipulation – these sound like the ideas of a science fiction writer, but, in fact, they are components of an exciting new approach to imaging local and metastatic tumors. In preclinical ...
Sep 17, 2014
0
0
Oncology & Cancer
Study finds worse survival when specific thyroid cancers spread to bone
When cancer metastases, bone unwittingly offers a friendly place for tumor cell growth—only to have its hospitality betrayed by pathologic fractures, spinal cord compression, the need for bone surgery or irradiation, and ...
Apr 14, 2017
0
6
Oncology & Cancer
Novel radiotracer advantageous for imaging of neuroendocrine tumor patients
For neuroendocrine cancer patients with liver metastases, a new radiopharmaceutical, 68Ga-DOTA-JR11, has shown excellent imaging performance in tumor detection, staging and restaging, providing important information to guide ...
Jun 25, 2020
0
2
Oncology & Cancer
Can RA-223 improve Enzalutamide efficacy for early castration resistant prostate cancer?
Globally, prostate cancer is the second most common type of cancer and the fifth leading cause of cancer-related death in men.
Dec 9, 2015
0
2
Oncology & Cancer
Study suggests new strategies against bone metastases from prostate cancer
When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year survival rate is only ...
Dec 2, 2019
0
2
Oncology & Cancer
Therapeutic inhibition of RANK pathway reduces breast cancer recurrence
Researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL), led by Dr. Eva Gonzalez-Suarez, have shown that pharmacological and genetic inhibition of signaling pathway RANK / RANKL leads to a significant reduction ...
Sep 13, 2016
0
1
